ATR and cancer: We screened a range of compounds capable of modulating cellular metabolism (Table 1) for their potential to increase γH2AX, a marker of DNA damage19 or pChk1 (S317), a marker of ATR activation, either alone or in combination with the Chk1 inhibitor V158411 (Chk1i), in HT29 and U2OS cancer cells.